What is Pulse4pulse?
Pulse4pulse is at the forefront of onsite diagnostic testing, specializing in the cardiovascular and autonomic nervous system. The company's core mission revolves around the early detection of chronic diseases in asymptomatic individuals, utilizing state-of-the-art medical devices to diagnose complex symptoms. By providing insightful medical reports, Pulse4pulse aims to improve patient compliance with treatment plans and enhance overall patient care. Their diagnostic capabilities extend to conditions such as peripheral artery disease, hypertension, and diabetic neuropathy, with a strategic focus on identifying chronic illnesses before they escalate to require more costly and invasive interventions.
How much funding has Pulse4pulse raised?
Pulse4pulse has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Pulse4pulse?
The substantial late-stage funding indicates Pulse4pulse is poised for significant scaling and market expansion. This capital infusion is likely to fuel further research and development, enhance manufacturing capabilities, and broaden the company's commercial reach. Strategic partnerships and potential acquisitions may also be on the horizon as Pulse4pulse solidifies its position as a leader in proactive health diagnostics. The company's focus on early detection aligns with a growing global trend towards preventative healthcare, suggesting a strong trajectory for future growth and innovation.
See full Pulse4pulse company page
